Delivery Order SPE2DB20D3101-SPE2DB22FJ7M5
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $3,389.60 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 0.3% ofloxacin ear drops in a 10mL size. This order was not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this IDC,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $5,469.25 firm fixed-price delivery order has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,640.84 contract is for the delivery of Ofloxacin 0.3% ear drops, 5ml, to support DLA Troop Support Medical programs and facilities. No set aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract...
- The Defense Logistics Agency awarded a $158 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561661389 units of ofloxacin 0.3% ear drops. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 1-2, 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to supply the antibiotic ear drops in support of the...
- The Defense Logistics Agency awarded a $315.60 delivery order to Amerisourcebergen Drug Corporation for 4561755480 units of ofloxacin 0.3% ear drops. The contract has a firm fixed price and place of performance in Conshohocken, Pennsylvania. It is for a one day period from August 9-10, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime contractor. No subcontractors or set aside designations were indicated. The...
- The Defense Logistics Agency awarded a $2,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561758398 units of ofloxacin 0.3% ear drops. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of August 9-10, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to supply the DLA with the generic antibiotic ear drops in support of the agency's mission to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,594.16 firm-fixed-price delivery order is for OFLOXACIN 0.3% EAR DROPS 10ML, with a completion date of September 13, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, a pharmaceutical product, with a ceiling value of $3,486.18. The contract was awarded on September 27, 2022, with a completion date of September 28, 2022, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award to Amerisourcebergen Drug Corp is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, with a ceiling value of $1,933.30. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of 4566353556 - OFLOXACIN 0.3% EAR DROPS 10ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,494.05 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) on November 6, 2024, with a completion date of November 7, 2024. The contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ7M5Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of 4557140794 Ofloxacin 0.3% Ear Drops 10ML to the place of performance in Conshohocken, PA. The fixed-price delivery order, valued at $2,808.76, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 5/6/22 |